search
Back to results

The Development of De-novo Stress Urinary Incontinence After Stage II-III Pelvic Organ Prolapse Surgery

Primary Purpose

Pelvic Organ Prolapse

Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
sacrospinous ligament fixation
Sponsored by
Kanuni Sultan Suleyman Training and Research Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pelvic Organ Prolapse focused on measuring sacrospinous ligament fixation, stress urinary incontinence

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Pelvic organ prolapse stage II-III
  • has no incontinence before surgery

Exclusion Criteria:

  • had surgery before
  • Pelvic organ prolapse stage I or IV

Sites / Locations

  • Kerem Doga Seckin

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

sacrospinosus fixation group

Arm Description

The group which sacrospinous fixation was performed

Outcomes

Primary Outcome Measures

development of stress urinary incontinence

Secondary Outcome Measures

postoperative vaginal length

Full Information

First Posted
July 14, 2017
Last Updated
January 27, 2019
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03221725
Brief Title
The Development of De-novo Stress Urinary Incontinence After Stage II-III Pelvic Organ Prolapse Surgery
Official Title
The Effect of Sacrospinous Ligament Fixation After Vaginal Hysterectomy to Development of De-novo Stress Urinary Incontinence and Postoperative Vaginal Length in Treating Stage II-III Pelvic Organ Prolapse Patients
Study Type
Interventional

2. Study Status

Record Verification Date
January 2019
Overall Recruitment Status
Completed
Study Start Date
February 1, 2017 (Actual)
Primary Completion Date
August 1, 2017 (Actual)
Study Completion Date
February 1, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kanuni Sultan Suleyman Training and Research Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Surgery for Stage II-III Pelvic organ prolapse

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pelvic Organ Prolapse
Keywords
sacrospinous ligament fixation, stress urinary incontinence

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
sacrospinosus fixation group
Arm Type
Experimental
Arm Description
The group which sacrospinous fixation was performed
Intervention Type
Procedure
Intervention Name(s)
sacrospinous ligament fixation
Intervention Description
sacrospinous ligament fixation will be applied to prevent vaginal vault prolapse
Primary Outcome Measure Information:
Title
development of stress urinary incontinence
Time Frame
in one year
Secondary Outcome Measure Information:
Title
postoperative vaginal length
Time Frame
in one year

10. Eligibility

Sex
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pelvic organ prolapse stage II-III has no incontinence before surgery Exclusion Criteria: had surgery before Pelvic organ prolapse stage I or IV
Facility Information:
Facility Name
Kerem Doga Seckin
City
İstanbul
Country
Turkey

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

The Development of De-novo Stress Urinary Incontinence After Stage II-III Pelvic Organ Prolapse Surgery

We'll reach out to this number within 24 hrs